REGN - Regeneron Pharmaceuticals Inc (REGN) RBC Capital Markets Global Healthcare Conference (Transcript)
2024-05-14 12:42:09 ET
Regeneron Pharmaceuticals Inc (REGN)
RBC Capital Markets Global Healthcare Conference
May 14, 2024 9:00 AM ET
Company Participants
Ryan Crowe - Senior Vice President of Investor Relations & Strategic Analysis
Chris Fenimore - Senior VP of Finance & CFO
Conference Call Participants
Brian Abrahams - RBC
Presentation
Brian Abrahams
All right. Let's get started. Welcome, everyone. I'm Brian Abrahams, senior biotech analyst here at RBC Capital Markets. Really pleased to have Regeneron here, represented by the CFO, Chris Fenimore, and their SVP of IR, Ryan Crowe.
Chris and Ryan, thank you guys so much for joining us.
Ryan Crowe
Thanks, Brian. Great to be here at the RBC conference. Just going to read a quick forward-looking statement disclaimer.
I'd like to remind you that our remarks made today may include forward-looking statements about Regeneron. Each forward-looking statement is subject to risks and uncertainties that could cause actual results and events to differ materially from those projected in such statements.
A description of material risks and uncertainties can be found in Regeneron's SEC filings. Regeneron does not undertake any obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise....
Regeneron Pharmaceuticals Inc (REGN) RBC Capital Markets Global Healthcare Conference (Transcript)